Lillian L. Siu
Princess Margaret Hospital
Toronto
Ontario
M5G2M9 Canada
Canada
Name/email consistency: high
- Brivanib alaninate for cancer. Diaz-Padilla, I., Siu, L.L. Expert. Opin. Investig. Drugs (2011)
- Early mortality and overall survival in oncology phase I trial participants: can we improve patient selection? Chau, N.G., Florescu, A., Chan, K.K., Wang, L., Chen, E.X., Bedard, P., Oza, A.M., Siu, L.L. BMC. Cancer (2011)
- Phase I study of MGCD0103 given as a three-times-per-week oral dose in patients with advanced solid tumors. Siu, L.L., Pili, R., Duran, I., Messersmith, W.A., Chen, E.X., Sullivan, R., MacLean, M., King, S., Brown, S., Reid, G.K., Li, Z., Kalita, A.M., Laille, E.J., Besterman, J.M., Martell, R.E., Carducci, M.A. J. Clin. Oncol. (2008)
- Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group Study. Siu, L.L., Soulieres, D., Chen, E.X., Pond, G.R., Chin, S.F., Francis, P., Harvey, L., Klein, M., Zhang, W., Dancey, J., Eisenhauer, E.A., Winquist, E. J. Clin. Oncol. (2007)
- Promising new targeted agents in head and neck cancer. Siu, L.L. Int. J. Radiat. Oncol. Biol. Phys. (2007)
- Phase I trial of sorafenib and gemcitabine in advanced solid tumors with an expanded cohort in advanced pancreatic cancer. Siu, L.L., Awada, A., Takimoto, C.H., Piccart, M., Schwartz, B., Giannaris, T., Lathia, C., Petrenciuc, O., Moore, M.J. Clin. Cancer Res. (2006)
- Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier?. Yee, K.W., Pater, J.L., Pho, L., Zee, B., Siu, L.L. J. Clin. Oncol. (2003)